Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry.
about
The molecular biology, biochemistry, and physiology of human steroidogenesis and its disordersStructure-based inhibitor design for an enzyme that binds different steroids: a potent inhibitor for human type 5 17beta-hydroxysteroid dehydrogenaseUDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cellsExpression of AKR1C3 in renal cell carcinoma, papillary urothelial carcinoma, and Wilms' tumor.Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases.Roscovitine protects murine Leydig cells from lipopolysaccharide-induced inflammationMechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault.The transcriptomics of de novo androgen biosynthesis in prostate cancer cells following androgen reductionProstatic disease and sexual dysfunctionMechanisms mediating androgen receptor reactivation after castration.Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride.Regulators of gene expression as biomarkers for prostate cancerAndrogen receptor is causally involved in the homeostasis of the human prostate endothelial cellVariant allele of HSD3B1 increases progression to castration-resistant prostate cancerTargeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).TGFβ1 alters androgenic metabolites and hydroxysteroid dehydrogenase enzyme expression in human prostate reactive stromal primary cells: Is steroid metabolism altered by prostate reactive stromal microenvironment?Estrogen and androgen signaling in the pathogenesis of BPH.Blockade of testicular and adrenal androgens in prostate cancer treatment.Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy.Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate.Intratumoral conversion of adrenal androgen precursors drives androgen receptor-activated cell growth in prostate cancer more potently than de novo steroidogenesis.Prostate organogenesis: tissue induction, hormonal regulation and cell type specification.Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol.Androgen receptor expression is regulated by the phosphoinositide 3-kinase/Akt pathway in normal and tumoral epithelial cellsCytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue.
P2860
Q24613957-2BDF5DF1-9478-4436-93C7-8D80BF144898Q27643293-A1D08B60-A095-45D0-92B6-BAC10974A57AQ28248233-A935C298-BD06-4156-B7FA-37194C62DF88Q33604649-7FAE22B1-AE98-4252-ACA5-1120B469D7E4Q33623428-60DE29CE-D9E1-476E-AF1F-90A24E788BF1Q33724078-B10CC19E-C000-4D90-87F8-01FC28E01936Q34013858-48317564-CBF9-4332-A791-30B611C0D3D1Q34127128-3D390124-9E90-434A-9708-72FD078C30D7Q35070009-08D0BA71-BC14-48E6-97F9-B1480168AF9BQ35633454-DDFEF620-41C9-42F9-A12E-86D8B6FD4DB9Q35869909-1164DF85-F010-4611-8494-3210208B3FD0Q36439912-29AF57DE-8B68-4609-8977-ABA36F1B90D5Q36692072-7ED0ADED-FE8E-4CA9-BDCC-4C29F9E51F97Q37016436-46AF06F1-F134-4548-8ED7-E18A61DF775FQ37207618-7E518C61-9028-422E-80C0-4BB2BA6679DCQ37340511-804CAD23-486D-49ED-B146-5C14FB8476E9Q37828063-6B06AFFD-69CC-48CE-97B2-A2EEF2D871E1Q37829637-0CF5F920-0FE3-4D6A-8809-1F3712CFA5DAQ37895401-EE913616-5BF1-4DDF-9F08-2F5B19B071E0Q38095223-2B78FE7E-34CB-4543-8D87-3CE28EB4430CQ39101405-A5899C4C-0B67-4FD7-B0D0-BCF160153E8FQ39235902-241FF3E0-9BF3-49A9-9994-35ED0E4E5F90Q39941487-128074B0-C551-472C-A2EB-908C0533313FQ40736171-8C9C756C-9663-4C23-8662-F43D339B5124Q44550678-D073FC27-234B-4436-A6F2-F8F5C7CC2ABC
P2860
Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Localization of type 5 17beta- ...... ation and immunocytochemistry.
@ast
Localization of type 5 17beta- ...... ation and immunocytochemistry.
@en
type
label
Localization of type 5 17beta- ...... ation and immunocytochemistry.
@ast
Localization of type 5 17beta- ...... ation and immunocytochemistry.
@en
prefLabel
Localization of type 5 17beta- ...... ation and immunocytochemistry.
@ast
Localization of type 5 17beta- ...... ation and immunocytochemistry.
@en
P2093
P356
P1433
P1476
Localization of type 5 17beta- ...... ation and immunocytochemistry.
@en
P2093
P304
P356
10.1210/EN.140.3.1481
P407
P577
1999-03-01T00:00:00Z